Insights

The Food and Drug Administration (FDA) has published revised draft guidelines in the Federal Register on promotional labeling and advertising considerations for the biologic and biosimilar industry, updating guidance from 2020. The quick revisions emphasize the fast-changing and rapidly growing nature of this industry.

In late December, the FDA released a guidance document that provides clarity for small businesses marketing direct-to-consumer (DTC) drug products on television or radio.  The Q&A followed the FDA’s November 2023 Final Rule amending DTC advertising regulations for prescription drugs. 

What do consumers think when they see a label on a package of supermarket chicken, beef or pork, stating that the meat has been “humanely raised?” The final week of February 2021 witnessed two important developments that shed light on a burgeoning legal attack on certain farming production and advertising practices. 

Companies worldwide are entering new product lines to address the COVID-19 pandemic, venturing into masks, ventilators, sanitizers, and other equipment and devices. With this move comes new legal challenges and opportunities for profit and prudent risk management. This webinar will share learnings on how savvy companies are making the most of their product pivots.